Barclays analyst Tom O’Malley raised the firm’s price target on Astera Labs (ALAB) to $87 from $70 and keeps an Overweight rating on the shares. Aries drove another quarter of upside, bridging the gap to a strong year ahead led by Scorpio and Gen 6, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB: